Plaintiff:  On or about January 4, 2003, the Plaintiff, Dan Hint began taking TrimSpa at the recommended dosage of one tablet, three times per day.  Plaintiff's use of TrimSpa was at all times within the guidelines and recommendations distributed by the Defendant.  On or about February 2, 2003, Dan Hint complained of a headache, weakness, numbness and difficulty moving his left upper and lower extremities and visited the ER at the St. Christopher  Regional Medical Center .  At the ER, it was determined that Dan had suffered a right parietal intracerebral hemorrhagic stroke.  Dan remained hospitalized for several weeks.  It is Plaintiffs' contention that the Defendant failed to exercise reasonable care in researching, designing, testing, developing, manufacturing, labeling, licensing, promoting, maketing, distributing, selling and/or otherwise introducing TrimSpa into commerce in that the defendants knew or should have known that TrimSpa created a high risk of unreasonably dangerous side effects, including but not limited to, an increased intra cerebral pressure, sometimes vasculitis, resulting in hemorrhagic strokes.  Plaintiff is seeking damages, including punitive damages.